Bergen, Norway, 7 January 2022 - BerGenBio ASA (OSE: BGBIO) (the "Company"), has been notified that Martin Olin, CEO and primary insider of BerGenBio ASA, has bought 10,000 shares in BerGenBio ASA at an average price of NOK 20.03 per share. After the transaction Mr. Olin holds 18,000 shares in BerGenBio ASA.

 

Please see the attached document for further details of the transaction.

Contact: 

ir@bergenbio.com

Rune Skeie, CFO, BerGenBio ASA 
rune.skeie@bergenbio.com 
 

This information is subject to the disclosure requirements pursuant to the EU Market Abuse Regulation (MAR) and section 5-12 of the Norwegian Securities Trading Act.  

 

https://news.cision.com/bergenbio-asa/r/bergenbio--mandatory-notification-of-trade-by-primary-insider,c3482555

https://mb.cision.com/Main/15728/3482555/1517829.pdf

https://mb.cision.com/Public/15728/3482555/95315c4c5b586b5c.pdf

(c) 2022 Cision. All rights reserved., source Press Releases - English